Rakta Chandana (Pterocarpus santalinus)

Rakta Chandana (Pterocarpus santalinus), or Red Sandalwood, contains pterostilbene, homopterocarpin, and santalin pigments that drive its pharmacological activity. These compounds exert anti-inflammatory and hepatoprotective effects primarily by scavenging free radicals and inhibiting acetylcholinesterase (AChE) enzyme activity.

Origin & History

Rakta Chandana is the heartwood of Pterocarpus santalinus, a deciduous tree native to the Eastern Ghats of southern India. The reddish wood is processed into powder, decoction, or paste and is rich in phenolic compounds, flavonoids, and terpenoids.

Historical & Cultural Context

In Ayurveda, Rakta Chandana is used for over 2,000 years to treat fever, skin issues, and as a styptic. It is also a component in Siddha formulations for cooling effects and as a natural dye in pharmaceuticals.

Health Benefits

• Anti-inflammatory properties are noted in traditional contexts, supported by preclinical studies.
• Hepatoprotective effects observed in rat models enhance liver antioxidant enzymes.
• Methanol extracts exhibit anticholinesterase (AChE) inhibitory activity in vitro and in vivo.
• Traditionally used for skin issues and eye disorders, though evidence is anecdotal.
• Antibacterial effects due to disruption of cell membrane integrity in microorganisms.

How It Works

Santalin and homopterocarpin in Pterocarpus santalinus inhibit NF-κB signaling and suppress pro-inflammatory cytokine release (TNF-α, IL-6), reducing inflammatory cascades at the cellular level. Methanol heartwood extracts inhibit acetylcholinesterase (AChE), prolonging acetylcholine availability at cholinergic synapses, which underlies its studied neuroprotective potential. Hepatoprotective activity is attributed to upregulation of antioxidant enzymes—superoxide dismutase (SOD), catalase, and glutathione peroxidase—in hepatic tissue, reducing oxidative damage.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified in the available sources. Evidence is limited to preclinical in vitro and animal studies. No PubMed PMIDs are available for human studies.

Clinical Summary

Preclinical evidence from rat models demonstrates significant hepatoprotective effects, with oral administration of P. santalinus extracts increasing hepatic SOD and catalase levels and reducing serum ALT/AST markers of liver injury. In vitro AChE inhibition studies using methanol heartwood extracts show dose-dependent inhibitory activity, with in vivo validation in rodent models supporting central cholinergic enhancement. Anti-inflammatory efficacy has been assessed primarily in animal models using carrageenan-induced edema paradigms, showing measurable reduction in paw edema. Human clinical trial data for Rakta Chandana are currently absent, meaning all mechanistic findings remain at preclinical or in vitro evidence levels.

Nutritional Profile

Rakta Chandana (Pterocarpus santalinus) is a non-food medicinal wood and is not consumed as a dietary source of macronutrients or micronutrients; therefore, conventional nutritional values (calories, carbohydrates, fats, proteins) are not applicable in standard dietary terms. Its profile is dominated by bioactive phytochemicals rather than nutritional constituents. Key bioactive compounds include: (1) Pterostilbene (a dimethylated analog of resveratrol) — a primary polyphenol with reported concentrations ranging approximately 0.1–0.5% in heartwood extract; high lipophilicity confers better oral bioavailability (~80%) compared to resveratrol. (2) Santalin A and Santalin B — red diaroylmethane pigments (xanthene-based colorants) present at approximately 0.3–1.0% in heartwood; responsible for characteristic red color; limited systemic bioavailability due to poor aqueous solubility. (3) Pterosupin and Liquiritigenin — flavanone glycosides present in trace amounts (<0.1% dry weight); moderate bioavailability via intestinal absorption. (4) Homopterocarpin and Pterocarpine — isoflavonoid compounds present at approximately 0.05–0.2% in heartwood; implicated in anticholinesterase and antimicrobial activity. (5) Savinin and Calocedrin — lignans identified in small quantities (~0.02–0.08%). (6) Tannins (including gallic acid derivatives) — present at approximately 2–5% in bark; contribute to astringent and hepatoprotective properties; moderate bioavailability. (7) Polysaccharides/fiber-like constituents in wood matrix — not bioavailable in conventional sense. (8) Trace minerals detected in ash analysis include calcium, magnesium, potassium, and iron, but concentrations are pharmacologically insignificant at typical medicinal doses. Bioavailability note: Most bioactive compounds are extracted via methanol, ethanol, or water decoctions; aqueous extracts yield primarily tannins and polar flavonoids, while lipophilic compounds like pterostilbene require ethanol/methanol extraction for meaningful yield.

Preparation & Dosage

No clinically studied dosage ranges from human trials are available. In traditional Ayurvedic use, it is utilized as powders, decoctions, or pastes, but specific quantities or standardization are not detailed. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Daruharidra, Turmeric, Neem, Ashwagandha, Ginger

Safety & Interactions

Rakta Chandana is generally regarded as safe at traditional Ayurvedic doses when used short-term, but no robust human safety trials have established a formal tolerable upper limit. Due to its AChE inhibitory activity, concurrent use with anticholinesterase drugs (e.g., donepezil, rivastigmine) or anticholinergic medications may produce additive or antagonistic pharmacodynamic interactions. Hepatoprotective constituents could theoretically interact with hepatically metabolized drugs by modulating CYP450 enzyme expression, though specific interaction data are lacking. Pregnant and breastfeeding women should avoid supplemental use due to insufficient safety data; traditional use in these populations is not well documented.